Prise en charge initiale actuelle des ­carcinomes ovariens séreux de haut grade avancés [Current management of advanced high grade serous ovarian carcinomas]

Details

Ressource 1Request a copy Under embargo until 16/04/2026.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_33A75F2F4F0F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Prise en charge initiale actuelle des ­carcinomes ovariens séreux de haut grade avancés [Current management of advanced high grade serous ovarian carcinomas]
Journal
Revue medicale suisse
Author(s)
Durand Y., Nicod Lalonde M., Hastir D., Astarita A., Mathevet P.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
16/10/2024
Peer-reviewed
Oui
Volume
20
Number
891
Pages
1848-1854
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Ovarian cancers are gynecological cancers with a poor prognosis. Most ovarian cancers are high-grade serous carcinomas. It is now accepted that they are very often tubal in origin. Their management has undergone major advances in recent years. Their clinical manifestations are not very specific, and no screening test has yet -proved its worth, which explains why they are often diagnosed late. The diagnostic phase is essentially based on ultrasound and abdomino-pelvic CT scans, for reasons of ease of access. Other -examination modalities, such as MRI and above all PET-Ct, are playing an increasingly important role in the initial management of extension or thera-peutic follow-up. Even with notable advances in diagnosis and treatment, the overall prognosis remains poor.
Keywords
Humans, Female, Ovarian Neoplasms/therapy, Ovarian Neoplasms/diagnosis, Ovarian Neoplasms/pathology, Cystadenocarcinoma, Serous/therapy, Cystadenocarcinoma, Serous/diagnosis, Cystadenocarcinoma, Serous/pathology, Prognosis, Neoplasm Grading
Pubmed
Create date
28/10/2024 14:09
Last modification date
29/10/2024 7:25
Usage data